DK0599968T3 - Oxazolidinonderivater, der er egnede som antiarytmi- og antifibrilleringsmidler - Google Patents

Oxazolidinonderivater, der er egnede som antiarytmi- og antifibrilleringsmidler

Info

Publication number
DK0599968T3
DK0599968T3 DK92918216T DK92918216T DK0599968T3 DK 0599968 T3 DK0599968 T3 DK 0599968T3 DK 92918216 T DK92918216 T DK 92918216T DK 92918216 T DK92918216 T DK 92918216T DK 0599968 T3 DK0599968 T3 DK 0599968T3
Authority
DK
Denmark
Prior art keywords
antiarrhythmic
derivatives suitable
oxazolidinone derivatives
agents
unsaturated
Prior art date
Application number
DK92918216T
Other languages
English (en)
Inventor
Stanford Salvatore Pelosi Jr
Chia-Nien Yu
Original Assignee
Procter & Gamble Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma
Application granted granted Critical
Publication of DK0599968T3 publication Critical patent/DK0599968T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK92918216T 1991-08-14 1992-08-10 Oxazolidinonderivater, der er egnede som antiarytmi- og antifibrilleringsmidler DK0599968T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74486591A 1991-08-14 1991-08-14
PCT/US1992/006682 WO1993004064A1 (en) 1991-08-14 1992-08-10 Cyclic urethanes useful as antiarrhythmic and antifibrillatory agents

Publications (1)

Publication Number Publication Date
DK0599968T3 true DK0599968T3 (da) 2000-04-17

Family

ID=24994270

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92918216T DK0599968T3 (da) 1991-08-14 1992-08-10 Oxazolidinonderivater, der er egnede som antiarytmi- og antifibrilleringsmidler

Country Status (23)

Country Link
US (1) US5994354A (da)
EP (2) EP0599968B1 (da)
JP (1) JPH06510285A (da)
AT (1) ATE188696T1 (da)
AU (1) AU665367B2 (da)
BR (1) BR9206353A (da)
CA (1) CA2115029C (da)
CZ (1) CZ283323B6 (da)
DE (1) DE69230563T2 (da)
DK (1) DK0599968T3 (da)
ES (1) ES2141725T3 (da)
FI (1) FI940658A (da)
GR (1) GR3032432T3 (da)
HU (1) HUT70144A (da)
IL (1) IL102791A (da)
MX (1) MX9204736A (da)
NO (1) NO300807B1 (da)
NZ (1) NZ243936A (da)
PL (1) PL171280B1 (da)
PT (1) PT100775B (da)
RU (1) RU2125568C1 (da)
SK (1) SK16994A3 (da)
WO (1) WO1993004064A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1231208A3 (en) * 1991-08-14 2003-12-10 Procter & Gamble Pharmaceuticals 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents
DK0599968T3 (da) * 1991-08-14 2000-04-17 Procter & Gamble Pharma Oxazolidinonderivater, der er egnede som antiarytmi- og antifibrilleringsmidler
AU665209B2 (en) * 1991-08-14 1995-12-21 Procter & Gamble Pharmaceuticals Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents
BR9910074A (pt) 1998-04-29 2000-12-26 Procter & Gamble Processo para fabricação de uréias 1,3-di-substituìdas-4-oxocìclicas
PL198951B1 (pl) 1998-04-29 2008-08-29 Procter & Gamble Sposób wytwarzania 1,3-dipodstawionych-4-oksocyklicznych moczników
MX2010003261A (es) * 2007-09-26 2010-08-18 Sinai School Medicine Analogos de azacitidina y usos de los mismos.

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE624402A (da) *
US2802002A (en) * 1956-07-18 1957-08-06 Norwich Pharma Co Series of new nu-(5-nitro-2-furyl) alkylidene-3-amino-5-tertiaryamino-methyl-2-oxazolidones and the preparation thereof
GB843834A (en) * 1957-05-13 1960-08-10 Norwich Pharma Co N-(5-nitro-2-furyl)-alkylidene-3-amino-5-tertiaryaminomethyl-2-oxazolidones and chemotherapeutic compositions containing them
FR1274399A (fr) * 1958-01-23 1961-10-27 Norwich Pharma Co Procédé perfectionné de préparation de dérivés du 5-nitro-2-formyl-furan
NL104211C (da) * 1958-02-28
US3004888A (en) * 1959-01-12 1961-10-17 Pfizer & Co C Mastitis treatment
NL266216A (da) * 1960-07-12
FR385M (fr) * 1960-08-17 1961-03-24 Norwich Pharma Co Nouveau médicament pour le traitement des infections staphylococciques et analogues.
CH398599A (fr) * 1961-03-24 1966-03-15 Om Lab Sa Procédé de préparation d'hydrazones de l'a-bromo-B-(5-nitro-2-furyl)acroléine
BE633841A (da) * 1962-06-21
NL120945C (da) * 1962-08-01
US3415821A (en) * 1965-09-07 1968-12-10 Norwich Pharma Co 1-(5-substituted)furfurylideneamino hydantoins and imidazolidinones
US3318878A (en) * 1966-04-14 1967-05-09 Smith Kline French Lab Nitrothiophene compounds
GB1279408A (en) * 1968-09-12 1972-06-28 Ciba Geigy Ag 5-nitro-2-furfurylideneamino-oxazolidinones
US3839567A (en) * 1969-04-17 1974-10-01 Schering Ag Pharmaceutical compositions comprising 3-(5-nitro-2-imidazolyl-methylen-amino)-2-oxazolidinones and their use in trichomoniasia
US3906101A (en) * 1969-06-05 1975-09-16 Ciba Geigy Corp Pharmaceutical compositions containing substituted 5-nitrofurfurylideneamino-oxazolidinones
US4775670A (en) * 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
US4393204A (en) * 1982-05-21 1983-07-12 Norwich Eaton Pharmaceuticals, Inc. 3-[[5-(4-Chlorophenyl)furfurylidene]amino]-5-(substituted)-2-oxazolidinones
US4543359A (en) * 1982-10-01 1985-09-24 Eaton Laboratories, Inc. Treating cardiac arrhythmias with dantrolene sodium
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums
US4720580A (en) * 1984-09-21 1988-01-19 American Home Products Corporation N-(aminoalkylene)benzenesulfonamides
US4707499A (en) * 1985-12-02 1987-11-17 G. D. Searle & Co. 3-alkyl-5-(substituted amino)methyl)dihydro-3-phenyl-2(3H)-furanones and imino analogs thereof used for treatment of arrhythmia
PH23283A (en) * 1986-02-26 1989-06-30 Eisai Co Ltd Piperidine derivative, pharmaceutical composition containing the same and method of use thereof
US4713832A (en) * 1986-04-11 1987-12-15 Ampex Corporation Programmable divider up/down counter with anti-aliasing feature and asynchronous read/write
IL79174A0 (en) * 1986-06-05 1986-09-30 Abic Ltd Water soluble salt of furaltadone
US4895867A (en) * 1986-06-26 1990-01-23 Norwich Eaton Pharmaceuticals, Inc. 2-(5-phenyl-2-furanyl)imidazoles useful as cardiotonic agents
US4886794A (en) * 1987-05-07 1989-12-12 A. H. Robins Company, Incorporated 4-[(α,α-diaryl)-hydroxymethyl]-1-piperidinylalkyl-cyclic carbamate derivatives as allergic response inhibitors
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
US4870095A (en) * 1988-06-13 1989-09-26 Sterling Drug, Inc. 1H-pyrazole-1-alkanamides, antiarrhythmic compositions and use
JPH0276882A (ja) * 1988-06-20 1990-03-16 Eisai Co Ltd 光学活性ヒダントイン誘導体
WO1990002744A1 (en) * 1988-09-15 1990-03-22 The Upjohn Company In position 3 substituted-5-beta-amidomethyl-oxazolidin-2-ones
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives
US5091426A (en) * 1989-06-23 1992-02-25 Norwich Eaton Pharmaceuticals, Inc. 5-phenyl-2-furan ketones and use as antiepileptic agents
US4966967A (en) * 1989-09-15 1990-10-30 Berlex Laboratories, Inc. 3,4,5,6-tetrahydro-2H-1,7,4-benzodioxazonines as cardiovascular agents
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
US4963561A (en) * 1990-02-28 1990-10-16 Sterling Drug Inc. Imidazopyridines, their preparation and use
US5066662A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors
US5086055A (en) * 1990-12-24 1992-02-04 A. H. Robins Company, Incorporated Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives useful in the treatment of allergic conditions
DK0599968T3 (da) * 1991-08-14 2000-04-17 Procter & Gamble Pharma Oxazolidinonderivater, der er egnede som antiarytmi- og antifibrilleringsmidler

Also Published As

Publication number Publication date
AU665367B2 (en) 1996-01-04
NZ243936A (en) 1996-10-28
FI940658A0 (fi) 1994-02-11
MX9204736A (es) 1993-11-01
RU2125568C1 (ru) 1999-01-27
WO1993004064A1 (en) 1993-03-04
CA2115029A1 (en) 1993-03-04
AU2467892A (en) 1993-03-16
ES2141725T3 (es) 2000-04-01
GR3032432T3 (en) 2000-05-31
IL102791A (en) 1998-06-15
DE69230563D1 (de) 2000-02-17
ATE188696T1 (de) 2000-01-15
EP0599968B1 (en) 2000-01-12
SK16994A3 (en) 1995-03-08
IL102791A0 (en) 1993-01-31
CZ283323B6 (cs) 1998-02-18
PL171280B1 (pl) 1997-03-28
EP0957103A1 (en) 1999-11-17
PT100775B (pt) 1999-09-30
NO940496D0 (no) 1994-02-14
CZ27894A3 (en) 1995-07-12
CA2115029C (en) 2002-03-26
HUT70144A (en) 1995-09-28
NO940496L (no) 1994-02-14
DE69230563T2 (de) 2000-09-14
EP0599968A1 (en) 1994-06-08
US5994354A (en) 1999-11-30
BR9206353A (pt) 1995-11-07
HU9400403D0 (en) 1994-05-30
JPH06510285A (ja) 1994-11-17
PT100775A (pt) 1994-01-31
FI940658A (fi) 1994-02-11
NO300807B1 (no) 1997-07-28

Similar Documents

Publication Publication Date Title
ATE138919T1 (de) Pyranylcyanoguanidinderivate
SE8004783L (sv) Delta?722-1,2,4triazolin-5-on-derivat
ES456287A1 (es) Procedimiento para la preparacion de derivados de ladano po-lioxigenados.
ATE108187T1 (de) Protease-hemmer.
TR24136A (tr) Ikameli tiyazollar ve bunlarin fungisitler yerine kullanimi
DK0706393T3 (da) Immun-undertrykkende og antiallergiske forbindelser, f.eks. N-(3-oxohexanoyl)homoserin-lacton
DK0599968T3 (da) Oxazolidinonderivater, der er egnede som antiarytmi- og antifibrilleringsmidler
ES468658A1 (es) Un procedimiento para preparar 4-alcohiltio-2-trifluorome- tilalcanosulfonanilidas y sus derivados
DE69426620T2 (de) Antidepressiva
ATE112682T1 (de) Isocarbacyclinderivate enthaltende antidiabetika.
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
TH14336EX (th) อนุพันธ์ต่าง ๆ ของพิเพอริดีน
SE8702986D0 (sv) Isokinolinderivat
ES454285A1 (es) Procedimiento para preparar derivados de 4-amina trans-deca-hidroquinolina.
DK305890A (da) Aminoketaler, deres fremstilling og deres anvendelse som fungicider
JPS5283677A (en) Derivative of 2-(7-indenyloxymethyl)-4-substituted morpholine
JPS5344575A (en) Preparation of hydantoin derivatives
KR920702364A (ko) 신규 세팔로스포린계 화합물
DE60316219D1 (de) Farbphotographisches lichtempfindliches Silberhalogenidmaterial
JPS5344574A (en) Hydantoin derivatives
JPS5416467A (en) Pyrrole derivative
SE9002445L (sv) Nytt cyklobutanderivat och foerfarande foer framstaellning av detsamma
ATE24887T1 (de) Cycloaliphatische alkohole.